Pfizer's COVID-19 Vaccine Approved for Use

Pfizer's COVID vax for kids belonging to the age group 5 to 11 years has been approved by Japan's Health Ministry.

Use of Pfizer COVID-19 vaccines has been approved by Japan's Health Ministry for inoculation in children aged between 5 and 11 as the nation continues to grapple with surging numbers of new cases.

The vaccine rollout for 8 million eligible children in this age group will start in March, informed sources said after its approval was fast-tracked by the Ministry, making it the first jab to become available to this age group in the country, reports Xinhua news agency.

Can a Person be Infected Twice With Omicron?
Covid re-infection with the Omicron variant is 5.4 times greater than that of the Delta variant. The best way to prevent yourself is by getting vaccined, wearing masks, washing hands properly, and avoiding crowded places.

‘Pfizer's COVID vax for kids belonging to the age group 5 to 11 years has been approved by Japan's Health Ministry.’

The vaccine, developed by the US pharmaceutical giant and its German partner BioNTech SE, at the moment is available to those in Japan aged 12 and over.

"We'd like to carefully explain the safety of the vaccine and start inoculation as soon as possible to those who wish to receive it," Noriko Horiuchi, minister in charge of promoting vaccine rollouts, told a press briefing.

"It is a big thing to have an inoculation option when some children are infected with the Omicron strain," she added.

Omicron may Cut Future Severity, Reveals Study
The new COVID-19 strain Omicron causes less severe illness and protects against the deadlier Delta variant, states a new study

Horiuchi's comments came as some parents have voiced concerns about possible side effects if they were to vaccinate their children.

Debate, meanwhile, continues among some health experts as to whether children so young need to be vaccinated as they are unlikely to develop serious symptoms if they do contract the virus.

Covid and Flu Booster to be Combined By 2023
Moderna is gonna combine Covid-19 and flu booster shot, which can be available in some countries by fall 2023.

Officials from a Ministry panel said the vaccine doses for those aged 5 to 11 contain one-third of the adult dose, with the active ingredients being the same, although the jab has been specially formulated for children.

While its effectiveness against the highly-transmissible Omicron variant cannot yet be verified, clinical trials held by Pfizer in the US and other countries for the vaccination of this age group showed that it was more than 90.7 percent effective in preventing COVID-19.

Source-IANS